A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.

Saved in:
Bibliographic Details
Title: A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.
Authors: Fruscio, R1 robilandia@gmail.com, Colombo, N2, Lissoni, A A1, Garbi, A1, Fossati, R3, Ieda', N1, Torri, V3, Mangioni, C1
Source: British Journal of Cancer. 2/26/2008, Vol. 98 Issue 4, p720-727. 8p. 6 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/sj.bjc.6604231